What We're Reading: Page 4
Industry reads hand-picked by our editors
Apr 03, 2024
-
AP News
A biased test kept thousands of Black people from getting a kidney transplant. It’s finally changing
-
Reuters
US takes next step in Medicare drug price negotiations with pharma companies
-
MedCity News
FDA Clears the First Digital Therapeutic for Depression, But Will Payers Cover It?
-
Wired
This Bag of Cells Could Grow New Livers Inside of People
Apr 02, 2024
Apr 01, 2024
Mar 29, 2024
Mar 28, 2024
-
The Economist
Artificial intelligence is taking over drug development
-
Bloomberg
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’
-
The Wall Street Journal
M&A Gathers Steam for Biotech Startups
-
Forbes
Base Editing Pioneer Nicole Gaudelli Joins GV
Mar 27, 2024
-
Wired
A dying child, a mother’s love and the drug that changed medicine
-
Bloomberg
Altimmune Obesity Drug Sheds Fat With Less Muscle Loss in Trial
-
Endpoints News
Pfizer stops one of two Phase 3 trials for sickle cell drug, still plans to seek approval in 2026
-
The Wall Street Journal
How Telehealth Widens Access to the Abortion Pill
Mar 26, 2024
-
The Colorado Sun
Amgen sues Colorado prescription drug board over Enbrel price cap
-
Boston Globe
Vertex considers leaving Fan Pier for other Seaport HQ
-
FirstWord Pharma
Moderna next-gen COVID booster hits the mark in late-stage study